These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 34474706)
1. How important is proper dosing for subcutaneous and sublingual allergy immunotherapy? Nelson HS Allergy Asthma Proc; 2021 Sep; 42(5):368-377. PubMed ID: 34474706 [No Abstract] [Full Text] [Related]
2. The use of standardized extracts in allergen immunotherapy. Nelson HS J Allergy Clin Immunol; 2000 Jul; 106(1 Pt 1):41-5. PubMed ID: 10887303 [TBL] [Abstract][Full Text] [Related]
3. Dosing of European sublingual immunotherapy maintenance solutions relative to monthly recommended dosing of subcutaneous immunotherapy. Larenas-Linnemann DE; Mösges R Allergy Asthma Proc; 2016; 37(1):50-6. PubMed ID: 26831847 [TBL] [Abstract][Full Text] [Related]
4. An evidence-based analysis of house dust mite allergen immunotherapy: a call for more rigorous clinical studies. Calderon MA; Casale TB; Nelson HS; Demoly P J Allergy Clin Immunol; 2013 Dec; 132(6):1322-36. PubMed ID: 24139829 [TBL] [Abstract][Full Text] [Related]
5. Dose-response relationship of a new Timothy grass pollen allergoid in comparison with a 6-grass pollen allergoid. Pfaar O; Hohlfeld JM; Al-Kadah B; Hauswald B; Homey B; Hunzelmann N; Schliemann S; Velling P; Worm M; Klimek L Clin Exp Allergy; 2017 Nov; 47(11):1445-1455. PubMed ID: 28696503 [TBL] [Abstract][Full Text] [Related]
6. Evidence-based dosing of maintenance subcutaneous immunotherapy: a contemporary review of state-of-the-art practice. Hoover H; Leatherman B; Ryan M; McMains K; Veling M Int Forum Allergy Rhinol; 2018 Jul; 8(7):806-816. PubMed ID: 29631326 [TBL] [Abstract][Full Text] [Related]
7. Maintenance dosing for sublingual immunotherapy by prominent European allergen manufacturers expressed in bioequivalent allergy units. Larenas-Linnemann D; Esch R; Plunkett G; Brown S; Maddox D; Barnes C; Constable D Ann Allergy Asthma Immunol; 2011 Nov; 107(5):448-458.e3. PubMed ID: 22018618 [TBL] [Abstract][Full Text] [Related]
8. The Art of Dosing for Subcutaneous Immunotherapy in North America. Nelson HS; Sowers T; Plunkett G; Nolte H; Rance K J Allergy Clin Immunol Pract; 2024 Jan; 12(1):13-22. PubMed ID: 37385447 [TBL] [Abstract][Full Text] [Related]
17. Long-term efficacy of the sublingual and subcutaneous routes in allergen immunotherapy. Penagos M; Durham SR Allergy Asthma Proc; 2022 Jul; 43(4):292-298. PubMed ID: 35818157 [TBL] [Abstract][Full Text] [Related]
18. Lack of effect of Timothy grass pollen sublingual immunotherapy tablet on birch pollen-induced allergic rhinoconjunctivitis in an environmental exposure unit. Ellis AK; Tenn MW; Steacy LM; Adams DE; Day AG; Walker TJ; Nolte H Ann Allergy Asthma Immunol; 2018 May; 120(5):495-503.e2. PubMed ID: 29432967 [TBL] [Abstract][Full Text] [Related]
19. Sublingual immunotherapy for allergic rhinitis. Wilson DR; Torres LI; Durham SR Cochrane Database Syst Rev; 2003; (2):CD002893. PubMed ID: 12804442 [TBL] [Abstract][Full Text] [Related]
20. Compatibility of imported fire ant whole body extract with cat, ragweed, Dermatophagoides pteronyssinus, and timothy grass allergens. Rans TS; Hrabak TM; Whisman BA; Grier TJ; LeFevre DM; Kwon PO; Tankersley MS Ann Allergy Asthma Immunol; 2009 Jan; 102(1):57-61. PubMed ID: 19205287 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]